Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment: A Cumulative 29-Year Safety Update.

Mitchell F BrinRussell S KirbyAnne SlavotinekAubrey M AdamsLori ParkerAhunna UkahLavinia RadulianMonica R P ElmoreLarisa YedigarovaIrina Yushmanova

Published in: Neurology (2023)

This analysis provides Class III data that demonstrate that the prevalence rate of major fetal defects among live births subsequent to in utero onabotulinumtoxinA exposure is comparable to reported background rates.

Keyphrases

pregnancy outcomes
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
pregnant women
prognostic factors
peritoneal dialysis
big data
machine learning
combination therapy
patient reported
data analysis